The Patent Finder

Acetylon Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Acetylon Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 21 patents it holds.

Back to Acetylon Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 9,145,412Selective HDAC1 and HDAC2 inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,096,549Selective HDAC3 inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,139,583Selective HDAC3 inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,125,131Selective HDAC3 inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,239,837Piperidine Derivatives as HDAC1/2 Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,358,421Piperidine Derivatives as HDAC1/2 Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,702,389Piperidine Derivatives as HDAC1/2 Inhibitors
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,272,084Histone Deacetylase 6 Selective Inhibitors for the Treatment of Cisplatin-Induced Peripheral Neuropathy
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,813,261Hdac Inhibitors, Alone or in Combination with BTK Inhibitors, for Treating Chronic Lymphocytic Leukemia
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,040,769Hdac Inhibitors for the Treatment of Diabetic Peripheral Neuropathy
Lapsed on the fee record
Ended Aug 7, 2026 · High confidence
Lapsed on the fee recordEnded Aug 7, 2026High confidence
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited